Lymphoproliferative Disorders

"Lymphoproliferative Disorders" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Disorders characterized by proliferation of lymphoid tissue, general or unspecified.

Descriptor ID	D008232
MeSH Number(s)	C15.604.515 C20.683.515
Concept/Terms	Lymphoproliferative Disorders Lymphoproliferative Disorders Disorder, Lymphoproliferative Disorders, Lymphoproliferative Lymphoproliferative Disorder X-Linked Lymphoproliferative Disorder X-Linked Lymphoproliferative Disorder Disorder, X-Linked Lymphoproliferative Disorders, X-Linked Lymphoproliferative Lymphoproliferative Disorder, X-Linked Lymphoproliferative Disorders, X-Linked X Linked Lymphoproliferative Disorder X-Linked Lymphoproliferative Disorders Epstein-Barr Virus Infection, Familial Fatal Epstein Barr Virus Infection, Familial Fatal Epstein-Barr Virus-Induced Lymphoproliferative Disease In Males Epstein Barr Virus Induced Lymphoproliferative Disease In Males Familial Fatal Epstein-Barr Infection Familial Fatal Epstein Barr Infection Immunodeficiency 5 Immunodeficiency 5s Duncan's Syndrome Lymphoproliferative Disease, X-Linked Disease, X-Linked Lymphoproliferative Diseases, X-Linked Lymphoproliferative Lymphoproliferative Disease, X Linked Lymphoproliferative Diseases, X-Linked X-Linked Lymphoproliferative Diseases Lymphoproliferative Syndrome, X-Linked, 1 Purtilo Syndrome Purtilo Syndromes Syndrome, Purtilo Syndromes, Purtilo X-Linked Lymphoproliferative Disease X Linked Lymphoproliferative Disease X-Linked Lymphoproliferative Syndrome Lymphoproliferative Syndrome, X-Linked Lymphoproliferative Syndromes, X-Linked Syndrome, X-Linked Lymphoproliferative Syndromes, X-Linked Lymphoproliferative X Linked Lymphoproliferative Syndrome X-Linked Lymphoproliferative Syndromes Duncan Disease Disease, Duncan Immunodeficiency, X-Linked Progressive Combined Variable Immunodeficiency, X Linked Progressive Combined Variable

Below are MeSH descriptors whose meaning is more general than "Lymphoproliferative Disorders".

Diseases [C]
Hemic and Lymphatic Diseases [C15]
Lymphatic Diseases [C15.604]
Lymphoproliferative Disorders [C15.604.515]
Immune System Diseases [C20]
Immunoproliferative Disorders [C20.683]
Lymphoproliferative Disorders [C20.683.515]

Below are MeSH descriptors whose meaning is related to "Lymphoproliferative Disorders".

Below are MeSH descriptors whose meaning is more specific than "Lymphoproliferative Disorders".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Lymphoproliferative Disorders" by people in this website by year, and whether "Lymphoproliferative Disorders" was a major or minor topic of these publications.

Bar chart showing 3 publications over 3 distinct years, with a maximum of 1 publications in 2002 and 2006 and 2015

To see the data from this visualization as text, click here.

Year	Major Topic	Total
2002	1	1
2006	1	1
2015	1	1

Below are the most recent publications written about "Lymphoproliferative Disorders" by people in Profiles.

Brar N, Butzmann A, Kumar J, Peerani R, Morgan EA, Grigoriadis G, Kumar B, Tatarczuch RM, Warnke RA, Ohgami RS. LIM domain only 2 (LMO2) expression distinguishes T-lymphoblastic leukemia/lymphoma from indolent T-lymphoblastic proliferations. Histopathology. 2020 Dec; 77(6):984-988.

View in: PubMed
Garc?a-Cadenas I, Y??ez L, Jarque I, Martino R, P?rez-Sim?n JA, Valc?rcel D, Sanz J, Berm?dez A, Mu?oz C, Calder?n-Cabrera C, Garc?a E, Alonso L, Su?rez-Lled? M, Gonz?lez Vicent M, Heras I, Viguria MC, Batlle M, V?zquez L, L?pez J, Solano C. Frequency, characteristics, and outcome of PTLD after allo-SCT: A multicenter study from the Spanish group of blood and marrow transplantation (GETH). Eur J Haematol. 2019 Jun; 102(6):465-471.

View in: PubMed
Xia D, Morgan EA, Berger D, Pinkus GS, Ferry JA, Zukerberg LR. NK-Cell Enteropathy and Similar Indolent Lymphoproliferative Disorders: A Case Series With Literature Review. Am J Clin Pathol. 2019 01 01; 151(1):75-85.

View in: PubMed
Tai R, Tirumani SH, Tirumani H, Shinagare AB, Hornick JL, Ramaiya NH. Is there a difference in post-transplant lymphoproliferative disorder in adults after solid organ and haematologic stem cell transplantation? Experience in 41 patients. Br J Radiol. 2015 Aug; 88(1052):20140861.

View in: PubMed
Al-Mansour Z, Nelson BP, Evens AM. Post-transplant lymphoproliferative disease (PTLD): risk factors, diagnosis, and current treatment strategies. Curr Hematol Malig Rep. 2013 Sep; 8(3):173-83.

View in: PubMed
Woelfel M, Bixby J, Brehm MA, Chan FK. Transgenic expression of the viral FLIP MC159 causes lpr/gld-like lymphoproliferation and autoimmunity. J Immunol. 2006 Sep 15; 177(6):3814-20.

View in: PubMed
Cho PS, Mueller NJ, Cameron AM, Cina RA, Coburn RC, Hettiaratchy S, Melendy E, Neville DM, Patience C, Fishman JA, Sachs DH, Huang CA. Risk factors for the development of post-transplant lymphoproliferative disorder in a large animal model. Am J Transplant. 2004 Aug; 4(8):1274-82.

View in: PubMed
Zivny J, Banner BF, Agrawal S, Pihan G, Barnard GF. CD4+ T-cell lymphoproliferative disorder of the gut clinically mimicking celiac sprue. Dig Dis Sci. 2004 Apr; 49(4):551-5.

View in: PubMed
Trimble LA, Prince KA, Pestano GA, Daley J, Cantor H. Fas-dependent elimination of nonselected CD8 cells and lpr disease. J Immunol. 2002 May 15; 168(10):4960-7.

View in: PubMed
Casato M, Mecucci C, Agnello V, Fiorilli M, Knight GB, Matteucci C, Gao L, Kay J. Regression of lymphoproliferative disorder after treatment for hepatitis C virus infection in a patient with partial trisomy 3, Bcl-2 overexpression, and type II cryoglobulinemia. Blood. 2002 Mar 15; 99(6):2259-61.

View in: PubMed

People

Explore

Similar Concepts

Top Journals